Weekly Round Up: Dell, Replimune, Snowflake Surged - podcast episode cover

Weekly Round Up: Dell, Replimune, Snowflake Surged

May 29, 20264 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Today's biggest winners and losers in the stock market, a look at the notable movers:

On this episode of Stock Movers:
- Dell Technologies (DELL) shares soared this week after the Texas-based company raised both its full year revenue and adjusted EPS outlooks on strong demand for its AI-powering servers. Analysts are widely impressed with the report, calling it “another blowout quarter.” The stock is up as much as 35%, its biggest intraday percentage jump since March 2024; with the move, the stock is now up more than 235% this year

- Replimune Group (REPL) shares soared as much as 82%, most intraday since October, after the biotech said it aligned with the FDA on a path to resubmit its Biologics License Application for RP1 in combination with nivolumab for advanced melanoma treatment. The Wall Street Journal previously reported the news.

- Snowflake (SNOW) shares surged by the most in more than five years after the software maker gave a stronger-than-expected annual outlook and signed a $6 billion multiyear agreement to use Amazon.com Inc.’s cloud services and chips.

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, podcasts, radio News.

Speaker 2

The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.

Speaker 1

Let's say a look at some stocks on the move this week. I'm Tim Stanovek with Christina Raffini. We're joined by Bloomberg News equity supporter Avalon Pronell. Hey have a on Happy Friday. Happy Friday.

Speaker 3

I mean, it's a lot of green on the screen, so definitely plenty to be happy about. We can start off with Dell.

Speaker 1

Let's talk about delay.

Speaker 4

I've been talking about Dell today.

Speaker 3

That's ticker Dell currently jumping forty three percent to end the week at a record high, also for its biggest weekly leap on record, and that's after detech companies AI server sales. Basically, we're stronger than expected across the board for the first quarter. It also boosted its full year revenue and adjusted earnings per share outlook. And I mean we didn't even mention computers, but those and also traditional servers did fantastics, So definitely a lot to cheer about there.

Speaker 1

We're talking earlier.

Speaker 4

Do you know this meme where they're like, if you if you onboard a company and they give you like an old Dusty Dell, you're like good to go. If they give you like an awesome chrome Mac book, like you should be concerned.

Speaker 1

Yes, yes, I just typed in Enrich, go on the Bloomberg terminal. Okay, it's the Bloomberg Billionaires Index updates every day. Thanks seeing what happened to Michael Dell's net worth today? He's jumped to sixth, the sixth place on the Bloomberg Billionaires Index. He's above Mark Zuckerberg now, who's at two hundred and twenty four billion dollars to just today with today and I know we're talking about this week avalon, but today his networth went up by thirty two point

nine billion dollars. Year to date, it's up more than eighty nine billion dollars. That's incredible, it's incredible. He's two places ahead of Jensen.

Speaker 4

Wow.

Speaker 1

Really Yeah, Jensen's number eight with one hundred and seventy five billion dollar net worth.

Speaker 4

Dell who knew, Yeah exactly.

Speaker 1

Okay, let's talk a little pharma healthcare.

Speaker 3

Absolutely so we have Repleamond that's ticker r ep L. It jumps seventy six percent this week to also have one of its best weeks on record. However, I'd actually point you to the month. It ended up more than two hundred and thirty eight percent and its best month on record, and that's after a whole lot of good news for biotechs across the board. The biotech said it plans to resubmit its skin cancer drug for FDA approval, not for the first or the second time, but now

the third time. It's seeking approval for the cancer drug after a lot of upheaval, to say the least, at the agency. Investors are seeing this as a really strong bullish signal that maybe the shakeup that happened earlier this month where we saw the FDA Commissioner commissioner exit, is actually going to be good news for biotech across the board.

Speaker 1

It's amazing up eighty five percent today, but it's still down this year by more than ten percent. Exactly.

Speaker 3

It really needs to get an approval in order to bring back some of that positive sentiment.

Speaker 4

I'm reading that it looks like the agency had some issues with following their guidance for clinical trials, which are really important for approvals. But as you said, new Agency, New Day new applications.

Speaker 1

Absolutely, all right, what else you got for us?

Speaker 3

And we can the day with moretech Snowflake, that's ticker son I love their ticker. It serged forty eight percent this week to cap off it's best week on record, and that's after the software maker gave a strongerdan expected for year guidance and also reported first quarter results earlier

this week that beat expectations. Also worth noting that they signed a six billion dollar multi year agreement with Amazon's Cloud to use their services and chips and Evercore, writing that despite all of the upheaval that we've been seeing across the AI space, especially how are they going to be handling software companies specifically, it seems like Snowflake maybe the one clear winner in the software space.

Speaker 2

The Stock Movers report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android